UMEM Educational Pearls

Title: Human African trypanosomiasis (HAT), also known as sleeping sickness

Category: International EM

Keywords: trypanosomiasis, Human African Trypanosomiasis, sleeping sickness, international (PubMed Search)

Posted: 12/19/2012 by Walid Hammad, MD, MBChB
Click here to contact Walid Hammad, MD, MBChB

 

·      A parasitic disease transmitted by the bite of the 'Glossina' insect  (tsetse fly.)

·      The disease is most prevalent in rural areas of Africa. Untreated, it is usually fatal. Infection with the genus Trypanosoma brucei gambiense may lead to chronic asymptomatic illness.

·      Travelers to endemic areas in Africa are risk becoming infected.

·      Symptoms resemble a viral illness; headaches, fever, weakness, pain in the joints, and stiffness. The parasite is able to crosses the blood-brain barrier and causes neurological symptoms, mainly psychiatric disorders, seizures, coma and ultimately death.

·      Diagnosis is by serological tests (Card Agglutination Trypanosomiasis Test or CATT). Confirmation of infection requires the performance of parasitological tests to demonstrate the presence of trypanosomes in the patient.

·      Treatment: four drugs are registered for the treatment of HAT: pentamidine, suramin, melarsoprol and eflornithine.

References

 

World Health Organization. (2010). Working to overcome the global impact of neglected tropical diseases. First WHO report on neglected tropical diseases. Available: http://whqlibdoc.who.int/publications/2010/9789241564090_eng.pdf. Last accessed 12/17/2012